Результаты поиска

Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and immunotherapy biomarkers.

PANoptosis is closely associated with tumorigenesis and therapeutic response, yet its role in multiple myeloma (MM) remains unclear. This study analyzed bulk transcriptomic and clinical data from the TCGA and GEO databases to identify seven PANoptosis-related genes (PRGs) using machine learning (LASSO regression and random forest models) and univariate Cox analysis, and constructed a prognostic risk model. The model demonstrated robust predictive performance across three external validation cohorts. High-risk patients exhibited higher tumor purity, increased tumor mutational burden, and distin

Research advances of lactylation modification in breast cancer.

Breast cancer (BC), a leading cause of cancer mortality in women, involves complex molecular mechanisms including post-translational modifications (PTMs). While common PTMs are well-studied, lactylation-a novel PTM linking metabolism to epigenetics-has emerged as a critical regulator in BC pathogenesis. The high concentration of lactate caused by the Warburg effect makes lactylation in tumor tissue possible. Machine learning enhances the discovery and analysis of lactylation sites by processing large datasets, revealing patterns that influence tumor behavior and patient outcomes. This review o

Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps.

Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-antibodies, and has a variable clinical course ranging from fully compensated low grade hemolysis to severe life-threatening cases. The rarity, heterogeneity and incomplete understanding of severe AIHA complicate the recognition and management of severe cases. In this review, we describe how severe AIHA can be defined and what is currently known of the severity and outcome of AIHA. There are no validated predictors for severe clinical course, but certain risk factors for poor outcomes (hospitalisation, trans

Functional genomics for breast cancer drug target discovery.

Breast cancer is a heterogeneous disease that develops through a multistep process via the accumulation of genetic/epigenetic alterations in various cancer-related genes. Current treatment options for breast cancer patients include surgery, radiotherapy, and chemotherapy including conventional cytotoxic and molecular-targeted anticancer drugs for each intrinsic subtype, such as endocrine therapy and antihuman epidermal growth factor receptor 2 (HER2) therapy. However, these therapies often fail to prevent recurrence and metastasis due to resistance. Overall, understanding the molecular mechani

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin's Lymphoma.

Telemonitoring is a great tool for vital signs monitoring in patients at high risk of severe life-threatening infections, such as haemato-oncological patients. As it can detect early symptoms of an infection, it allows early reaction and, therefore, can help prevent the progression of the infection into severe sepsis. We present a case report of a 69-year-old patient with aggressive non-Hodgkin lymphoma undergoing intensive immunochemotherapy. The treatment was complicated by two episodes of Gram-negative bacterial (G-) infection. During the first episode, the patient was admitted to the hospi

Совпадение в полном тексте источника
… Before the chimeric antigen receptor-T cell therapy was initiated, the lymphoma progressed; therefore, a combination of rituximab, gemcitabine, and oxaliplatin was used as a bridge therapy. On the fifth day of the second cycle of this regimen, the patient developed another infectious complication. …

Роль ДИОТРЕИТОЛ в разрешении предтрансмиссии иммуногематологии у пациентов, получающих anti-CD38 Моноклональные антитела для лечения множественной миеломы.

ВВЕДЕНИЕ: Daratumumab (Darzalex; Janssen-Cilag Pty Ltd), a/ anti-CD38 Моноклональная антитела (MoAb) продемонстрировала высокую эффективность в лечении рецидива и рефрактной множественной миеломы (MM). Она стоит как пионер anti-CD38 Минздрав, утвержденный Управлением лесного хозяйства США (УЛХ)2015) и GGA Australia (Australia)2017). Направляя CD38 на клетки миэломы, Daratumumab создает проблему в проведении предтрансфузионных испытаний, вызывая панреактивность при косвенных тестах на антиглобулин (ИАТ) из-за выражения CD38 на красных клетках. В этом исследовании изучается роль ДИОТРЕИТОЛ (ДТТ)

A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy.

Antibody-Drug Conjugates (ADCs) represent an innovative class of potent anti-cancer compounds that are widely used in the treatment of hematologic malignancies and solid tumors. Unlike conventional chemotherapeutic drug-based therapies, that are mainly associated with modest specificity and therapeutic benefit, the three key components that form an ADC (a monoclonal antibody bound to a cytotoxic drug via a chemical linker moiety) achieve remarkable improvement in terms of targeted killing of cancer cells and, while sparing healthy tissues, a reduction in systemic side effects caused by off-tum

Активация клеток, похожих на ретинальный макрофаж, и разбавление слоя ячеек связаны с инвалидностью и МРТ-повреждением при множественном склерозе.

Множественный склероз — хроническая нейро-воспалительная болезнь, при которой клетки, подобные микроглии и макрофаге, играют центральную роль в прогрессии заболеваний. Сетчатка как центральная нервная система, доступная для неинвазивной съемки, открывает уникальное окно в эти процессы. ЦЕЛЬ: Цель этого исследования состояла в том, чтобы определить, связаны ли характеристики клеток сетчатки с макрофагом и толщиной клеточного слоя с клинической инвалидностью и ударом магнитного резонанса у пациентов с множественным склерозом.МЕТОДЫ: В ходе этого перекрестного наблюдения пациенты, страдающие множ

Oncologic Applications of Artificial Intelligence and Deep Learning Methods in CT Spine Imaging-A Systematic Review.

In spinal oncology, integrating deep learning with computed tomography (CT) imaging has shown promise in enhancing diagnostic accuracy, treatment planning, and patient outcomes. This systematic review synthesizes evidence on artificial intelligence (AI) applications in CT imaging for spinal tumors. A PRISMA-guided search identified 33 studies: 12 (36.4%) focused on detecting spinal malignancies, 11 (33.3%) on classification, 6 (18.2%) on prognostication, 3 (9.1%) on treatment planning, and 1 (3.0%) on both detection and classification. Of the classification studies, 7 (21.2%) used machine lear

Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases.

Bone and joint-related diseases, including osteoarthritis (OA), rheumatoid arthritis (RA), and bone tumors, pose significant health challenges due to their debilitating effects on the musculoskeletal system. 14-3-3 proteins, a family of conserved regulatory molecules, play a critical role in the pathology of these diseases. This review discusses the intricate structure and multifunctionality of 14-3-3 proteins, their regulation of signaling pathways, and their interactions with other proteins. We underscore the significance of 14-3-3 proteins in the regulation of osteoblasts, osteoclasts, chon

Cytokine-Engineered Chimeric Antigen Receptor-T Cell Therapy: How to Balance the Efficacy and Toxicity.

Chimeric antigen receptor (CAR)-T cell immunotherapy has revolutionized the paradigm in hematological malignancies. However, its efficacy in treating solid tumors remains limited because the immunosuppressive tumor microenvironment (ITME) seriously blocks T cell activation, infiltration, and proliferation. Cytokines, driving potent assisted function by enhanced T cell expansion, persistence, and direct tumor cell killing, have long been acknowledged as promising candidates combined with CAR-T cells to improve treatment outcomes. Despite their preclinical success, significant toxicity occurs in

Colorectal cancer with first known case of simultaneous bilateral tibial metastases.

The most common osseous metastatic regions for colorectal cancer are the lumbar and sacral vertebrae and the pelvis. There are few reported cases of isolated solitary tibial metastasis, and simultaneous bilateral solitary tibial metastases in colorectal cancer are even rarer. A 62-year-old female patient was admitted to our inpatient clinic 3 years after receiving initial chemotherapy for a rectosigmoid adenocarcinoma with liver metastasis. The patient complained of left leg pain. Radiographs and magnetic resonance imaging revealed a 3- × 3-cm mass in the right proximal tibia and a 2- × 7-cm m

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Эпилептические изъятия как однократное представление радиологически изолированного синдрома: доклад по делу и обзор литературы.

Множественный склероз (MS) является наиболее распространенным долгосрочным воспалительным состоянием, влияющим на центральную нервную систему у взрослых. Вместе с тем изъятия редко описываются как первое представление MS или как единственное проявление радиологически изолированного синдрома (РИС) или клинически изолированного синдрома (СНГ). Диагностика MS, как правило, требует клинических данных о неврологических недостатках и вспомогательных радиологических данных; однако РИС характеризуется случайными результатами магнитно-резонансной съемки (MRI), которые указывают на наличие MS в отсутств

A new hope with CAR T-cell therapy for refractory idiopathic inflammatory myopathies: a systematic review.

BACKGROUND: Treatment options for refractory idiopathic inflammatory myopathies (IIMs) remain limited, and sustained remission is frequently not achieved with conventional immunosuppression or biologic agents. Chimeric antigen receptor (CAR) T-cell therapy has been approved for multiple refractory hematologic malignancies and is increasingly being explored as an immune reset strategy for autoimmune diseases. MAIN BODY: This Review synthesizes all available clinical evidence on CAR T-cell therapy in adult and pediatric IIM, with the aim of raising awareness within the rheumatology community re

Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review (protocol).

ObjectiveTo determine the efficacy and safety of CAR-T therapy in the treatment of patients with hematologic malignancies, in comparison with other current therapies.DesignA living systematic review.MethodsWe will include randomized trials evaluating the effect of CAR-T therapy versus other active treatments, hematopoietic stem cell transplantation, best supportive care or any other intervention in patients with hematologic malignancies. Non-randomized primary studies will be searched in case we found no direct evidence from randomized controlled trials. Two reviewers will independently screen

CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights.

Chimeric antigen receptor T (CAR-T) cell therapy has undergone vigorous development in recent years, yet it still faces significant challenges and difficulties in its clinical application and further development. A systematic synthesis of global trends in CAR-T clinical trials is essential to identify knowledge gaps, optimize treatment strategies, and guide future research directions. This review analyzed 1,580 CAR-T clinical trials registered at ClinicalTrials.gov as of April 2024, and extracted characteristic data in multiple dimensions, including target specificity, treatment indication, an

Изучение того, что имеет наибольшее значение для пациентов при повторном рефрактальном лечении нескольких миелом: канадский эксперимент по дискретному выбору пациентов, лиц, обеспечивающих уход, и врачей.

КОЛИЧЕСТВО: Возвращение/изъятие нескольких миелом (RRMM) оказывает значительное воздействие на качество жизни пациентов. В рамках этого исследования были изучены особенности лечения, характерные для RRMM в Канаде, при этом были сопоставлены параметры традиционных методов лечения с характеристиками химической антигенной рецепторной (CAR) T-клетокой терапии. Она была направлена на понимание предпочтений пациентов и того, каким образом те, кто ухаживает за больными, и специалисты в области здравоохранения (ХЦП) воспринимают эти предпочтения. МЕТОДЫ: Был проведен эксперимент по дискретному выбору

Эффективность и безопасность карфилзомиба, помалидомида и дексаметазона в реанимированном/охотничьем миеломе: ретроспективный анализ из Китая.

КОЛИЧЕСТВО: Помалидомид, лекарство от иммуномодуля (ИМИД) следующего поколения, и карфилзомиб, новый протеиновый ингибитор (ПИ), были отдельно одобрены в комбинированных режимах для реактивной/рефрижераторной множественной миеломы (RRMMM). Однако реальные данные, особенно по китайским пациентам, страдающим рентгеновским лечением, включая линалидомид и бортезомиб, по-прежнему ограничены. МЕТОДЫ: Мы ретроспективно проанализировали пациентов RRM, прошедших курс лечения с КДП в период с октября 2022 и декабрь 2024 на two Китайские центры. Результаты: Это исследование включало в себя 34 Пациенты, п

Acute myeloid leukemia: focus on novel therapeutic strategies.

Acute myeloid leukemia (AML) is a heterogeneous disease with variable clinical outcomes. Cytogenetic analysis reveals which patients may have favorable risk disease, but 5-year survival in this category is only approximately 60%, with intermediate and poor risk groups faring far worse. Advances in our understanding of the biology of leukemia pathogenesis and prognosis have not been matched with clinical improvements. Unsatisfactory outcomes persist for the majority of patients with AML, particularly the elderly. Novel agents and treatment approaches are needed in the induction, post-remission